Pacira BioSciences (PCRX) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Pacira BioSciences (PCRX) over the last 16 years, with Q3 2025 value amounting to $3.2 million.
- Pacira BioSciences' Non Operating Income rose 37123.7% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.7 million, marking a year-over-year decrease of 12983.82%. This contributed to the annual value of -$373000.0 for FY2024, which is 10053.76% down from last year.
- According to the latest figures from Q3 2025, Pacira BioSciences' Non Operating Income is $3.2 million, which was up 37123.7% from -$10.7 million recorded in Q2 2025.
- In the past 5 years, Pacira BioSciences' Non Operating Income registered a high of $27.3 million during Q4 2022, and its lowest value of -$23.4 million during Q1 2023.
- Moreover, its 5-year median value for Non Operating Income was -$6.7 million (2021), whereas its average is -$2.4 million.
- Its Non Operating Income has fluctuated over the past 5 years, first crashed by 33167.04% in 2021, then soared by 146915.89% in 2025.
- Quarter analysis of 5 years shows Pacira BioSciences' Non Operating Income stood at -$10.4 million in 2021, then surged by 361.88% to $27.3 million in 2022, then fell by 3.37% to $26.3 million in 2023, then tumbled by 137.27% to -$9.8 million in 2024, then surged by 132.21% to $3.2 million in 2025.
- Its last three reported values are $3.2 million in Q3 2025, -$10.7 million for Q2 2025, and $6.7 million during Q1 2025.